Eli Perencevich is an Infectious Disease provider in Baltimore, Maryland. Dr. Perencevich is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, and Severe Acute Respiratory Syndrome (SARS).

Dr. Aaron M. Milstone is a professor of pediatrics at the Johns Hopkins University School of Medicine. He holds a joint appointments in Epidemiology and Health Policy and Management at the Bloomberg School of Public Health. A pediatric epidemiologist, Dr. Milstone specializes in treating infectious diseases in children. He serves as an associate hospital epidemiologist at The Johns Hopkins Hospital and the pediatric lead for infection prevention for the Johns Hopkins Health System. Dr. Milstone earned his medical degree from Yale University School of Medicine. He completed both a pediatrics residency and a research fellowship in pediatric infectious diseases at Children's Hospital of Philadelphia. He also completed a pediatric infectious diseases fellowship at Johns Hopkins. He holds a M.H.S. (Graduate Training Program in Clinical Investigation) from the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins University School of Medicine. Dr. Milstone joined the Johns Hopkins faculty in 2007. His research interests focus on antibiotic resistance and prevention of healthcare-associated infections. He had led numerous clinical trials including the Pediatric SCRUB Trial and TREAT PARENTS Trial testing strategies to prevent organism transmission and healthcare-associated infections. He is principal investigator of the BrighT STAR Collaborative, guiding hospitals nationwide to reduce over-testing as a strategy to reduce antibiotic use and resistance. Dr. Milstone is a fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society for Healthcare Epidemiology of America. His many other professional honors include the Pediatric Infectious Diseases Society’s 2014 Young Investigator Award, the inaugural 2013 Caroline B. Hall Clinical Innovation Award, and the Society for Healthcare Epidemiology of America 2018 Mentor Scholar Award, and 2023 Johns Hopkins Medicine Armstrong Award for Excellence in Quality & Safety. Dr. Milstone is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Severe Acute Respiratory Syndrome (SARS), and Neonatal Sepsis.

Dr. Cosgrove is a Professor of Medicine in the Division of Infectious Disease (ID) at Johns Hopkins University School of Medicine and has a joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Research for the ID Fellowship Program and PI of the T32 training grant that supports ID fellow training. She serves as the Director of the Department of Antimicrobial Stewardship and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Cosgrove’s research interests include the epidemiology and outcomes of antimicrobial resistance, the development of tools and programs to promote the rational use of antimicrobials, the prevention of hospital-acquired infections, and the epidemiology and management of S. aureus bacteremia. Early in her career, she recognized the critical need to study antimicrobial stewardship strategies and has led a series of outcomes studies over the past 20 years that have defined the practice of antimicrobial stewardship in the United States. Her recent research focuses on strategies for implementation of antimicrobial stewardship activities across all healthcare settings via a large, multi-center project including hospitals, long-term care facilities and ambulatory practices funded by the Agency for Healthcare Research and Quality, and approaches to improve how antibiotics are given via a randomized trial to compare intravenous and oral therapy for Gram negative bacteremia funded by PCORI. She is the PI of the Johns Hopkins Prevention Epicenter, a Centers for Disease Control and Prevention-funded program that integrates antimicrobial stewardship, healthcare epidemiology, human factors engineering, data science, and implementation science to address knowledge gaps and develop strategies to optimize patient safety by preventing transmission of pathogens and improving antibiotic use in diverse healthcare settings and patient populations. She is a past voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. She is a Past President of the Society for Healthcare Epidemiology’s Board of Directors. Dr. Cosgrove received her undergraduate degree from Columbia College, her medical degree from Baylor College of Medicine, and her master of science degree in epidemiology from Harvard School of Public Health. She completed her postgraduate training in internal medicine at The Johns Hopkins Hospital and underwent subsequent training in ID at Beth Israel Deaconess Medical Center. Dr. Cosgrove is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, and Pseudomonas Stutzeri Infections.

Karen Carroll is an Infectious Disease provider in Baltimore, Maryland. Dr. Carroll is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, Meningitis, and Bone Marrow Aspiration. Dr. Carroll is currently accepting new patients.

James Ley is an Infectious Disease provider in Elkton, Maryland. Dr. Ley has been practicing medicine for over 39 years and is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Cellulitis, Hospital-Acquired Pneumonia, COVID-19, and Osteomyelitis.

Lisa Maragakis, M.D., M.P.H., FSHEA, FIDSA is a professor of medicine and epidemiology at Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health. Dr. Maragakis is the Senior Director of Infection Prevention, for The Johns Hopkins Health System and the Hospital Epidemiologist for The Johns Hopkins Hospital. In these roles, she is responsible for the conceptualization, planning, implementation, and development of the Johns Hopkins Health System's infection control and prevention program. Her research interests are the epidemiology, prevention and control of healthcare-acquired infections and antimicrobial-resistant gram-negative bacilli. Dr. Maragakis serves as the Executive Director of the Johns Hopkins Hospital Biocontainment Unit and as Incident Commander for the Johns Hopkins Medicine COVID-19 response. She also serves as the IDSA Co-Chair for the 2022 Update of the Compendium of Strategies to Prevent Healthcare-Associated Infections, and as Co-Chair of the Centers for Disease Control and Prevention's Healthcare Infection Control Practices Advisory Committee (HICPAC). Dr. Maragakis is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Ebola Virus Disease, Severe Acute Respiratory Syndrome (SARS), Viral Hemorrhagic Fever, and Bone Marrow Aspiration.

Dr. Gloria K. Aggrey graduated from Case Western Reserve University School of Medicine in 2004. She completed a residency in Internal Medicine in the Rhode Island Hospital/Miriam Hospital Program at Brown University in 2007. She then completed a fellowship in Infectious Diseases at Boston University in 2009. Dr. Aggrey is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Sepsis, Strep Throat, Pneumonia, and Asymptomatic Bacteriuria.

Rameet Thapa is an Infectious Disease provider in Cumberland, Maryland. Dr. Thapa is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Cellulitis, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Osteomyelitis. Dr. Thapa is currently accepting new patients.

Mark Landrum, M.D. received his medical degree from the University of Maryland School of Medicine. He completed residency training in Internal Medicine and Pediatrics and a fellowship in Infectious Diseases at the University of Maryland Medical System. His areas of interest include general Infectious Diseases, HIV care, and travel health. He serves as the Chief of the Division of Infectious Diseases at Johns Hopkins Howard County Medical Center and is the physician leader for epidemiology and infection prevention for the Johns Hopkins community hospitals. Learn more at idmaryland.com. Videos 2015 Innovations in Clinical Care Award - Mark Landrum, M.D., Howard County General Hospital. Dr. Landrum is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Sepsis, Pneumonia, Cellulitis, and Methicillin-Resistant Staphylococcus Aureus (MRSA).

Styliani Karanika is an Infectious Disease provider in Baltimore, Maryland. Dr. Karanika is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA) and Pseudomonas Stutzeri Infections.

William F. Wright, D.O., M.P.H, Assistant Professor of Medicine, completed medical training residency in internal medicine and adult infectious diseases fellowship at Pennylvania State University Medical School. He pursued further training in Clinical Pathology/Medical Microbiology at Yale University School of Medicine, New Haven (2009) and completed his Master in Public Health (2007) at Drexel University School of Public Health, Philadelphia. His research interests include fever of unknown origin (FUO), antimicrobial resistance and therapeutic discoveries, molecular mechanisms of resistance, and the impact of diagnostic clinical microbiology on the practice of infectious diseases. He currently serves as clinical director for the inpatient infectious diseases consult services and services for the management of outpatient parenteral antimicrobial therapy (OPAT) at Johns Hopkins Bayview Medical Center. His outpatient clinical practice focuses on general infectious diseases, infections in burn patients, infections in immunocompromised patients, and travel-related infections. He primarily sees patients at Johns Hopkins Greenspring Station, Johns Hopkins Bayview Outpatient offices, and also attends on the inpatient infectious disease consult service at the Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital. Dr. Wright is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Meningitis, and Endocarditis.

Eyad Cheikh, M.D. received his medical degree from the University of Damascus School of Medicine. He completed residency training in Internal Medicine at Saint Agnes Hospital in Baltimore, and finished his fellowship in Infectious Diseases at Carilion Clinic in Carilion Roanoke Memorial Hospital. Dr. Cheikh's areas of interest include general Infectious Diseases, HIV care and infection control. Learn more at idmaryland.com. Dr. Cheikh is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Sepsis, Hospital-Acquired Pneumonia, Pneumonia, and Multisystem Inflammatory Syndrome in Children (MIS-C).

Dr. Christopher K. Lippincott is an infectious diseases specialist at the Johns Hopkins University School of Medicine. He is the Clinical Director for the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis. He is an expert in the care of patients with mycobacterial infections (NTM and tuberculosis), HIV/AIDS, Lyme disease, and general infectious diseases. He provides teaching to medical students, residents and fellows at the Johns Hopkins University School of Medicine. Dr. Lippincott earned his M.D. at the University of Virginia School of Medicine. He completed his residency at The Ohio State University Wexner Medical Center and infectious diseases fellowship at the University of North Carolina Hospitals. He also earned a Master of Public Health in epidemiology from the University of North Carolina at Chapel Hill in 2013. Prior to joining Johns Hopkins University in 2015, Dr. Lippincott practiced infectious diseases internationally for Medecins Sans Frontieres (Abkhazia, Georgia) and Right to Care (Johannesburg, South Africa). Dr. Lippincott’s research interests include mycobacterial infections (NTM and tuberculosis) and bronchiectasis. Dr. Lippincott is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Swimming Pool Granuloma, Nontuberculous Mycobacterial Lung Disease, Osteomyelitis, and Osteomyelitis in Children.

Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin. Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. He earned his M.D. from the Columbia University College of Physicians and Surgeons. His research interests include tick-borne diseases and point of care information technology. Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America. Dr. Auwaerter is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Lyme Disease, Infectious Myocarditis, Babesiosis, and Osteomyelitis.

Dr. Bass attended Duke University for college and medical school, and received residency training in internal medicine and an MPH degree from the University of Pittsburgh. He completed a fellowship in general internal medicine at Johns Hopkins, and joined the Johns Hopkins faculty in 1989. His strongest research interests are in evidence-based medicine and assessment of the effectiveness, safety, and costs of medical and surgical management strategies. He has been the Director of the Johns Hopkins Evidence-based Practice Center since 2001. His teaching activities focus on medical student education at the interface between medicine and public health. He is the Director of the medical school's course on Foundations of Public Health, and Co-Director of the medical school's Scholarly Concentration in Public Health Research. He was the Director of the General Internal Medicine Fellowship at Johns Hopkins for 15 years. He served as the Editor of the Journal of General Internal Medicine for 5 years, and was the founding Editor-in-Chief of a journal dedicated to community-based participatory research called Progress in Community Health Partnerships. He has been the CEO of the Society of General Internal Medicine since 2017. He has published more than 250 peer-reviewed articles and over 50 evidence reports. He continues to have a clinical practice as a general internist. Dr. Bass is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Testicular Cancer, Varicose Veins, Type 2 Diabetes (T2D), Leydig Cell Testicular Tumor, and Orchiectomy.

Dr. Maryana Shenderov is a clinician at the Johns Hopkins University School of Medicine, having joined in 2016. Her area of clinical expertise is infectious disease. She earned her M.D. from SUNY Downstate Medical Center. She completed her residency and a fellowship in infectious diseases at the University of Maryland Medical Center. Dr. Maryana Shenderov sees patients at the Greenspring Station and Bartlett Infectious Diseases Clinics and also provides inpatient consultations at Johns Hopkins Hospital. She is committed to excellence in patient care, multi-disciplinary collaboration, and patient-centered care. Dr. Shenderov is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Osteomyelitis, Osteomyelitis in Children, SAPHO Syndrome, and Chronic Recurrent Multifocal Osteomyelitis.

Dr. Motaz Baibars is a hospitalist at Johns Hopkins Howard County Medical Center. Dr. Baibars is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Sepsis, Pneumonia, Hospital-Acquired Pneumonia, Hip Replacement, and Endoscopy.

Dr. Moon’s area of clinical expertise is infectious diseases. She earned her M.D. at the Ross University School of Medicine. Dr. Moon completed her residency at Allegheny General Hospital and performed a fellowship in infectious diseases at Penn State Milton S. Hershey Medical Center. Dr. Moon is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Hepatitis C, Hepatitis, Osteomyelitis, and HIV/AIDS.

Charles Bornmann is an Infectious Disease provider in Baltimore, Maryland. Dr. Bornmann is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Infective Endocarditis, Sepsis, Osteomyelitis, and Myelitis.

Mamuka Machaidze is an Infectious Disease specialist and a Hospital Medicine provider in Baltimore, Maryland. Dr. Machaidze is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Infectious Arthritis, and Pustules.